Studies have shown that IL-4 has a stimulatory effect on proliferation and survival in pancreatic cancer cells acting as an autocrine growth factor, and cancer-derived IL-4 may also inhibit cancer-directed immune surveillance in vivo, thereby promoting pancreatic tumor growth and metastasis [31]. The gene discussed is IL4; the disease is familial pancreatic carcinoma.